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Introduction
 Non-communicable diseases (NCDs) are the main 
cause for mortality and burden worldwide. Malignant 
neoplasms, an important and growing category of NCDs, 
are cause of 13.3% global death. From all malignancies 
in Iran (47,100), gastric and esophageal cancers were 
responsible for 7,800 and 3,500 death in 2008 respectively. 
At the same year in Eastern Mediterranean Region 
(EMRO), estimated burdens for these cancers were 
260,000 and 238,000 (WHO Global Health Observatory 
Data Repository, 2011). A recent study from Golestan 
province (an endemic region of GI cancers), has reported 
stomach and esophagus cancers as first and second top 
incident malignancies (Roshandel et al., 2012). Incidence 
rate of esophageal and gastric cardia cancers has risen in 
recent decades in some regions of the world (Macfarlane 
et al., 1994; Devesa et al., 1998; Botterweck et al., 2000; 
Newnham et al., 2003; Zhou et al., 2008) but in some 
reports, incidence of esophageal cancer has not largely 
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Abstract
 Background: Gastric and esophageal cancers are among the most lethal human malignancies worldwide. Of 
all malignancies estimated in Iran (47,100), gastric and esophageal cancers were responsible for 7,800 and 3,500 
deaths in 2008 respectively. The present study aimed to provide an image of patho-epidemiological characteristics 
with their trends during two past decades with emphasis on topographic, morphologic, and some demographic 
features. Materials and Methods: In a hospital-based retrospective study in 2009, all pathological reports from 
esophageal endoscopies and gastric biopsies through a 20 years period (1989-2008) were collected and analyzed 
in four interval periods (five years each). Also, all eligible samples in hospital archives were enrolled for further 
testing. Besides, demography, topography and morphology of all samples were determined and analyzed by 
statistical software. Results: No significant statistical difference was seen in frequency of esophageal and gastric 
tumors throughout the study. Esophageal cancer cases were older than gastric. Sex ratio was 2.33/1 and men 
had a higher rate of both esophageal and gastric tumors. Stomach cancer included 64.3% of all cases. Inferior 
third and end of esophagus were common locations for esophageal tumors whereas proximal stomach was 
common for gastric tumors. Squamous cell carcinoma and adenocarcinoma were common morphological types 
of tumors in esophagus and stomach respectively. Conclusions: Morphological trends showed an increase of 
esophageal adenocarcinoma and diffuse/intestinal ratio in stomach cancers. Trends in incidence from gastric 
cancer decreased based on topographic studies but we could not find a topographical trend toward cardia. 
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changed (Aragones et al., 2010). For better assessment of 
esophageal and gastric cancer, risk factors such as clinical 
manifestations, pathological characteristics, prognostic 
factors and survival need to be considered. Pathological 
characteristic controls the modality of treatment and has 
direct relationship with prognosis (Siewert et al., 2000; 
Moghimi-Dehkordi et al., 2008). Cancer registries have 
taking place for a longtime in developed countries, but 
they are fairly new. In Iran, cancer registry has a short 
history and information on esophageal and gastric cancers 
with pathological characteristics is limited to different 
local researches with relatively small sample size, different 
methods and diverse results (Abdi-Rad et al., 2006; 
Bafandeh et al., 2006; Moghimi-Dehkordi et al., 2008; 
Mousavi and Somi, 2009; Babaei et al., 2010). Failure to 
focus longitudinal studies on pathological characteristics 
is a potential weakness for having an image of these 
important cancers in Iran. This study aimed to draw an 
image of pathological characteristics and their trends 
during two past decades with emphasis on topographical, 
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morphological, and some demographic characteristics. 
 
Materials and Methods
Setting of study and sample
 In a hospital-based retrospective study at Boo-Ali 
Sina (Avicenna) Hospital in 2009, all the pathological 
reports from endoscopic esophageal and gastric biopsies 
through a 20-year periods, five years interval (1989-2008) 
were collected to find out demographic, topographic, and 
morphological characteristics of the patients. Since the 
hospital did not have any surgery ward, all the samples 
had collected by endoscopy. Each sample belonged to 
one patient and we didn’t check more than one sample for 
each case. All the eligible reported samples in the archive 
were enrolled and suspicious cases were excluded from 
this study.
Method of diagnosis
 All samples were collected based on their numbers in 
archive. New cuts from preserved blocks were prepared. 
Pathologist was blind to the previous diagnoses in the 
reports. Repeated blind check was performed by another 
pathologist only if there was a large difference between 
two previous diagnoses. Final decision was made by all the 
previous diagnoses. To evaluate prognostic significance, 
Lauren classification was used. 
Classifications
 Topography: For esophageal cancer, location of the 
lesion classified as superior or esophageal upper (EUT: 
first 15-21 centimeters from dental arch), esophageal 
middle (EMT: 22-31 centimeters), inferior or esophageal 
lower (ELT: 32-41 centimeters), esophageal lower 
end (ELE: only for adenocarcinoma of lower end of 
esophagus), and unknown or esophageal not otherwise 
specified (ENOS). 
 For gastric cancer, location of the tumor was defined 
as GC (cardia), GF and B (fundus or body or both), GDIS 
(pylorus or antrum or both), overlap locations (GM1: 
cardia-fundus and body, GM2: fundus and body-distal 
(without cardia), GM3: total gastric (cardia, fundus and 
body, distal)), and Gastric Not Otherwise Specified or 
unknown (GNOS). GR is standing for relapse.
 Morphology: There are two main categories of 
malignancies in the upper gastrointestinal tract: common 
and certain carcinoma and uncertain carcinoma. 
 Common carcinomas are dividing to adenocarcinoma 
(AC) and squamous cell carcinoma (SCC). There are four 
types of AC: intestinal, diffuse, mixed and non specified 
AC (ANOS) (Nagini, 2012). 
 SCC is dividing to four categories based on the grade 
of differentiation: squamous well differentiated (SWD), 
squamous moderately differentiated (SMD), squamous 
poorly differentiated (SPD), and squamous not otherwise 
specified (SNOS). 
 Uncertain carcinoma are poorly differentiated 
carcinoma (CPD) that could be either poorly differentiated 
AC, poorly differentiated SCC, carcinoma not otherwise 
specified (CNOS), or epithelial differentiation but with 
doubt on glandular differentiation. 
Statistical analysis
 PASW Statistics 18.0 software (IBM Corporation, 
release 2009) were used for statistical analyses. Descriptive 
statistical methods (frequency, mean±standard deviation, 
crosstabulation, and median) were used for describing data 
and somer’s d statistic was used to find out any specific 
directional measure and trend during the time. Chi square 
test, independent samples t-test and analysis of variance 
(ANOVA) were performed to explore relationship between 
different categorical and numerical variables.
Results 
 Throughout the study, 1134 biopsy samples were 
reported as malignant tumors and studied in two different 
groups: group 1: esophageal (405, 35.7%), and group 
2: gastric cancers (729, 64.3%). The results showed the 
highest cumulative incidence rate in the first period of 
study (1989-94, 29.6%) for both groups, but no significant 
statistical difference was seen in frequency of esophageal 
and gastric tumors throughout the study. Figure 1 shows 
trend of registered patients of esophageal and gastric 
tumors. 
Demography
 The mean age for all patients was 65.4±12.1 with 
a median of 67 years. The mean age were changed 
throughout the study, started from 62.1±12.6 in the first 
five years and had reached to 67.8±11.8 in the last. The 
difference between periods was statistically significant 
(p<0.001) and in a post-hoc analysis, the mean age in the 
first five years was different from all next three periods 
(p=0.002, <0.001, and <0.001).
 Male patients (794 cases, 70%) had a large 
predominance (Sex ratio=2.33/1). Men had a higher age 
than women (66.3±11.5 vs. 63.2±13.3) and there was a 
significant difference between two sexes (p<0.001).
 Esophagus- The mean age in group 1 was 66.3±11.8 
and median was 68 years. The youngest and oldest patients 
were 27 and 100 years old. In group 1, there were 245 
(60.5%) male cases with higher rate of esophageal tumors 
(60.5%). Sex ratio was 1.53. 
 Stomach- The mean age in group 2 was 64.8±12.3 
and showed a statistically significant difference from 
group 1 (p=0.049) and the median was 66 years. The 
youngest and oldest patients of gastric cancer were 9 (a 
case of malignant lymphoma) and 93. In group 2, a greater 
Figure 1. Trend of Registered Patients of Esophageal 
and Gastric Tumors
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male predominance was seen (549, 75.3%) with higher 
rate of gastric tumors (75.3%). Sex ratio was 3.04 and in 
both sexes gastric tumors were more common although 
frequency of esophageal and gastric tumors were close 
in females (52.9% and 47.1% in women vs. 69.1% and 
30.9% in men). Overall, we found a significant difference 
between two sexes at the location of the tumor (p<0.001). 
Topography
 Topographic studies displayed that tumors of 729 cases 
(64.3%) were belonged to stomach and 405 (35.7%) to 
esophagus. Based on pathological assessment, we could 
not certify the topographic site of tumor in more than a 
half of samples.
 ELT was common topographic site for esophageal 
tumors in men (54.5%) whereas EMT was common 
(40.8%) in females and difference was significant 
between two sexes (p=0.037). In gastric tumors, common 
topographic site was GDIS in both sexes (32.1% and 
47.7%). 
 Our results showed that ELE was common topographic 
site of tumors in the first five years of the study (57.9%) 
and ELT was common in three next intervals and the 
20 years trend was significantly different between 
topographic sites (p<0.001). Figure 2 shows the trends 
of changes in different topographical sites of esophageal 
tumors.
 Among gastric cancers, GC was common in first and 
second periods of study (51.9, and 35.7%) and GDIS was 
common in third and forth (42.2, and 35.3%). The trends 
were significantly different (p=0.008). Figure 3 shows the 
trends of changes in topographical sites of gastric tumors.
Morphology
 Morphology results displayed that AC was common 
upper GI tract tumor (60.9%). Alternatively, SCC (23.1%), 
uncertain carcinomas (10.5%), and other tumors (4.8%) 
were associated to upper GI. Two main types of AC 
(intestinal and diffuse) were responsible for more than a 
half of all tumors (51.7%) and intestinal type was common 
carcinoma (30.6%). 
 Esophagus- Among esophageal tumors, SCC was 
common tumors (64.4%) and SMD was common subtype 
of SCC (35.8%). AC were responsible for near one 
Figure 2. Trend of Changes in Topographic Sites for 
Esophageal Tumors
Figure 3. Trend of Changes in Topographic Sites for 
Gastric Tumors
Figure 4. Trend of Main Types of Esophageal 
Carcinomas
Figure 5. Trend of Changes in Main Types of Gastric 
AC
Table 1. Frequency of Different Topographic Sites for 
Esophageal Tumors
 Frequency % Percent within Percentage based
   certain topographical on anatomic 
   sites region
EUT 4 1.0 2.7 2.7
EMT 40 9.9 26.7 26.7
ELT 74 18.3 49.3 70.6
ELE 32 7.9 21.3 
ENOS 255 63.0  
Total 405 100.0 100.0 100.0
*EUT: esophagus, upper third; EMT: esophagus, middle third; ELT: esophagus, 
lower third; ELE: esophagus, lower end; ENOS: Esophagus, not otherwise specified
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Table 2. Frequency of Different Topographic Sites for 
Gastric Tumors
 Frequency % Percent within Percentage based
   certain topographical on anatomic 
   sites region
Total proximal GCardia 57 7.8 20.7 55.3
 GF and B 86 11.8 31.3 
 GM1 9 1.2 3.3 
Distal GDIStal 99 13.6 36.0 36.0
Distal+proximal GM2 14 1.9 5.1 8.7
 GM3 10 1.4 3.6 
GR  2 0.3
GNOS  452 62.0
Total  729 100.0 100.0 100.0
*Gcardia: gastric, cardia region; GF and B: gastric, fundus and body; GM1: gastric, 
cardia-fundus and body; GM2: gastric, fundus and body-distal (without cardia); 
GM3: total gastric (cardia, fundus and body, distal); GNOS: gastric not Otherwise 
specified; GR: gastric, relapsed
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fourth (22%) of esophageal tumors. Most of esophageal 
carcinomas were belonged to male patients (77.5% for 
AC and 55.2% for SCC) but results from SCC suggested 
that male and female patients consist of 67.6% and 85.4% 
cases respectively. Statistical analysis showed a significant 
difference between sexes (p<0.001). The mean age of AC 
and SCC was 65.7±11.9 and 66.2±11.7 and the difference 
was not statistically significant. The mean age of well 
differentiated SCC was the highest among specified SCC 
tumors 68.1±12.0.
 Common morphology for esophageal tumors was 
SMD (74, 30.2% for men and 71, 44.4% for women).
 Trend of AC was increased throughout the study from 
57.2% in the first five-year period to 66.9% in the last 
whereas SCC was decreased from 25.2% to 20.2% and 
changes was significant throughout the study (p=0.007, 
Figure 4). However, the incidence rate of SWD tumors 
showed an increase from 9.3% in first five years to 25% 
in the last. SMD was decreased from 62.8% to 51.9%, but 
the trend of changes was not significant.
 Stomach- Within all gastric tumors, AC was 
responsible for 82.5%. The common AC was intestinal 
(40.4%) and diffused type (29.0%). Well differentiated 
intestinal AC was common subtype of intestinal (14.5%). 
Among gastric AC, intestinal type had a higher age 
(67.2±10.1 vs. 63.5±13.4) and the difference between two 
types (intestinal and diffuse) was significant (p=0.001). 
Intestinal AC was common morphologic type (347, 
30.8%) and in male patients AI was common (269, 
34.1%). In females squamous cell carcinoma had the 
highest frequency (117, 44.8%). Among gastric tumors, 
the highest incidence rate was AIW (106, 14.7%) while in 
esophageal tumors, moderately differentiated squamous 
cell carcinoma was common (145, 35.8%). In both sexes, 
AC was common gastric tumors (85.8% in male vs. 85.9% 
in female) and among subtypes of gastric AC, intestinal 
type was the highest in both sexes (43.1% in male vs. 
35.9% in female) and AIW was common type. Within 
subtypes of diffuse AC, signet ring cell carcinoma was 
common type after not otherwise specified in both sexes 
(28.2% in men vs. 27.3% in women).
 When trends of the two main types of gastric AC (AI 
and AD) were assessed, intestinal type was changed from 
66.7% to 50.4% (versus change from 33.3% to 49.6% for 
diffuse AC) and these changes were significant (p=0.013, 
Figure 5). The trend of changes in frequency of signet ring 
cell subtype was not significant (Even after combining all 
categories with signet ring cell in tumor).
Discussion
Esophagus, a recent report from an adjacent province 
in Iran has shown similar age status and sex ratio that 
confirms our results (Mansour-Ghanaei et al., 2012). In 
agreement with previous studies (Kumar, 2007; Bennett 
and Goldblum, 2009), our result explained that SCC was 
common esophageal cancer in both sexes and mostly had 
moderate degree of differentiation but AC was observed 
mostly in male sex in compatible with other studies 
(Botterweck et al., 2000). The highest incidence rate of 
SCC in esophagus, were observed in the middle third 
(Kumar, 2007; Bennett and Goldblum, 2009; Yahyapour 
et al., 2012) and in our study, most of esophageal cancers 
in female were seen in the middle while lower third was 
the most common site in male. This difference might 
be related to higher incidence rate of AC in male and 
its location that made it predominant. This finding is 
compatible with previous study (Newnham et al., 2003) 
and a recent one from Iran (Mansour-Ghanaei et al., 
2012). Our observation showed that AC of lower end of 
esophagus was considered as a lower third tumor, thus it is 
the most common location for cancer. This finding is also 
similar to other study (Bafandeh et al., 2006) but our study 
was performed based on a retrospective revision of files so 
it is possible to have some difficulties about distinguishing 
between lower esophageal end and cardiac tumors. 
Proportion of SCC and AC among all esophageal 
cancers widely varies in different studies from different 
countries. While we found a ratio of 2/1 for SCC/AC 
and SCC has majority of tumors in some other reports 
too (from Japan (26/1) (Shibata et al., 2008) and Iran 
(4/1) (Mansour-Ghanaei et al., 2012)), in the US, SCC 
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Table 3. Morphology of All Tumors (total, gastric and esophageal) Based on Biopsies
Type Sub-type Count Percent Esophageal % of esophageal Gastric % of gastric
   of total  tumors  tumors
Intestinal AC AI 347 30.6% 52 12.8% 295 40.4%
Diffuse AC AD 238 21.1% 27 6.7% 211 29.0%
mixed diffuse and intestinal AC ADI 33 2.9% 4 1.0% 29 4.0%
Not specified AC ANOS 72 6.3% 6 1.5% 66 9.1%
Total adenocarcinoma  690 60.9% 89 22% 601 82.5%
Squamous cell carcinoma (SCC) SNOS 20 1.8% 20 4.9%  
 SWD 43 3.8% 43 10.6%  
 SMD 145 12.8% 145 35.8%  
 SPD 53 4.7% 53 13.1%  
Total SCC  261 23.1% 261 64.4%  
Uncertain carcinoma  120 10.5% 41 10.2% 79 10.9%
Other tumors  55 4.8% 14 3.4% 41 5.5%
Missing  8 0.7% - - 8 1.1%
Total  1134 100% 405 100% 729 100%
*AC: Adenocarcinoma; AI: adenocarcinoma, intestinal type; AD: adenocarcinoma, diffuse type; ADI: adenocarcinoma, mixed intestinal and diffuse types; ANOS: 
adenocarcinoma, not otherwise specified; SNOS: squamous cell carcinoma, not otherwise specified; SWD: squamous cell carcinoma, well differentiated; SMD: squamous 
cell carcinoma, moderately differentiated; SPD: squamous cell carcinoma, poorly differentiated
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and AC are equal and even a higher rate of AC in recent 
decades has been recorded (Kumar, 2007; Bennett and 
Goldblum, 2009). 
Several line of studies have shown a decrease in 
proportion of SCC in recent decades (Devesa et al., 
1998; Botterweck et al., 2000; Makhdoomi et al., 2005; 
Aragones et al., 2010; Gopala Krishnappa et al., 2013) but 
the severity varied between different countries (Triboulet 
and Mariette, 2008). In Japan there wasn’t any change 
(Shibata et al., 2008). Some parts of north of Iran (Golestan 
province) located in the worldwide belt of esophageal 
cancer. According to cancer registry report on 2006, we 
have had 90% SCC among all esophageal cancers in 
Golestan province. Similar study was performed from 
Tabriz province (in northwest of Iran) (Bafandeh et al., 
2006). In our study in Qazvin province (one of central 
provinces of Iran), this rate was 64% which was closed to 
the results obtained from Tabriz province (Bafandeh et al., 
2006). This finding suggested that the proportion of SCC 
among all esophageal cancers is related to its prevalence. 
Therefore in case of a lower rate of esophageal cancer, 
the proportion of SCC was decreased. To find out these 
changes in pathological pattern, risk factors frequency 
like decrease in smoking (result in lower rate of SCC 
or rising AC due to more gastroesophageal reflux) and 
Barrett’s esophagus rates (result of obesity or anti-H.pylori 
treatments, deletion of an inhibiting factor on AC of lower 
end of esophagus) need to be considered. Interestingly, 
there are some evidences to suggest that H.pylori 
infection may protect to develop gastroesophageal reflux 
disease (GERD) and its complications but this idea is 
still controversial (Kumar, 2007; Bennett and Goldblum, 
2009). Mean age of patients in our study was similar to 
previous studies (Bafandeh et al., 2006, Kumar, 2007). 
In addition, our results suggested that sex ratio was 1.53 
which is more than study performed in Tabriz province 
(Bafandeh et al., 2006). 
Stomach, in the present study, the mean age of patients 
was about 65 years old which was less than Chinese 
study (Zhou et al., 2008) and another report from Iran 
(Aghaei et al., 2013) but similar to some other studies 
and references (Kumar, 2007; Lauwers, 2009; Babaei 
et al., 2010; Rampazzo et al., 2012; Rodríguez-Vargas, 
2013). In Iran, a study from Khuzestan province (in south 
of the country) showed a mean age of 60 years (Hajiani 
et al., 2006) subsequently a study from a referral center 
in Tehran showed mean age of 56 years (Abdi-Rad et al., 
2006). The result obtained from later study showed a large 
difference from our study. We suggested that one reason 
for these differences could be the variation in the method 
of sampling. In our study, samples were provided through 
endoscopic biopsy but the method of sampling in center of 
Tehran (Abdi-Rad et al., 2006) was surgery. Considering 
an average of 10 months survival for patients of gastric 
cancer in Iran (Sadighi et al., 2005), we assumed that many 
cases of higher age didn’t enter to the study.
Sex ratio in our study was higher than some other 
studies (Newnham et al., 2003; Hajiani et al., 2006; 
Mousavi and Somi, 2009; Rampazzo et al., 2012; Aghaei 
et al., 2013; Rodríguez-Vargas, 2013) and what has been 
reported in Global Cancer Statistics (Jemal et al., 2011). 
In addition, increasing in mean age of patients during the 
term of the study was similar to other studies (Popielaet 
al., 2002; Zhou et al., 2008).
Morphology, result obtained from morphological study 
showed that common morphologic gastric cancer was 
AC and predominance of intestinal type. Our study was 
similar to the other studies, (Zhou et al., 2008; Mousavi 
and Somi, 2009; Babaei et al., 2010; Rampazzo et al., 
2012; Rodríguez-Vargas, 2013).
We found a gradual decrease in the ratio of intestinal/
diffuse types of AC result from widespread treatment 
following decrease in gastritis due to H.pylori (as a risk 
factor for intestinal type of gastric adenocarcinoma) in 
recent decades. Also, we found an increase in proportion 
of diffuse type during the term of study which wasn’t 
applicable to signet ring type. In other words, rising in 
proportion of diffuse type was not due to an increase 
in proportion of signet ring type. These findings were 
in contrast to some studies but similar to some reports 
(Kaneko and Yoshimura, 2001; Henson et al., 2004).
Topography, although the topographic distribution of 
gastric cancer throughout the study was compatible with 
reference books (Kumar, 2007; Lauwers, 2009) there were 
some differences at frequency and topography of gastric 
cancer with domestic and abroad studies. 
For example, gastric cancer in north of Iran is 5 folds 
more frequent than south (Mousavi and Somi, 2009) and 
in Ardebil province (that has the highest rate of gastric 
cancer in Iran (Babaei et al., 2010)) the rate of cardiac 
cancer is 3 folds more than other regions of the country. 
In our study, topographic distribution of gastric 
cancer showed a large difference with result obtained 
from Ardebil province (with a higher rate of cardiac 
tumor, Babaei et al., 2010) and was more compatible with 
Khuzestan province (with a higher rate of distal tumors, 
Mousavi and Somi, 2009).
On the other hand, the rate of cardiac cancer in 
present study was lower than some studies from the US, 
UK, European countries (Babaei et al., 2010), and China 
(Zhou et al., 2008) with topographical location more than 
30% of all gastric cancers. In contrast, the rate of cardiac 
cancer in other reports was less than ours including studies 
from Japan, Korea, and South America with a rate of 
10% (Babaei et al., 2010) and from Brazil with 14.3% 
(Rampazzo et al. 2012). Because there are a few western 
pattern of topography of gastric cancer, thus the trend 
overall might be reverse. In some other studies, mostly 
from Asia, the trend is similar to our study and there is 
no trend of migration to cardia, maybe due to traditional 
eastern nutritional habits (Lee et al., 2003; Makhdoomi 
et al., 2005).
One possible interpretation for this migration is a 
change in topographic classification and its defects in the 
studies. Decrease in defects of the reports of topographical 
classification is associated with more report of cardiac 
tumors. 
In a study from UK in 1998, more than ¾ of gastric 
cancers had specific morphology with unknown subtypes 
in more than 50% of cases (Newnham et al., 2003). In 
addition, a large percentage of gastric cancers in registries 
in past decades didn’t have histological confirmation and 
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increasing diagnosis of cardiac tumor has showed an 
association with rising in histological confirmation (Islami 
et al., 2004; Aragones et al., 2010). Another possible 
explanation might be a more tendency in reporting cardiac 
tumors. In past decades, pathologists didn’t mention to 
separate cardiac tumors from other parts of the stomach. 
Indeed, an independent code for cardiac tumors was used 
since 1970 in Europe although there wasn’t a consensus in 
determination of anatomical location of cardia until 1999 
(Aragones et al., 2010).
One important suggestion that need to be considered 
in morphological and topographic changes would be error 
due to investigation criteria. For example, study from 
Golestan province on 1969-71 (Islami et al., 2004) showed 
the ratio of esophageal /gastric cancer was estimated about 
8/1 but in another study on 2001 (Islami et al., 2004) it 
was estimated about 2/1. 
This notable change might be result of changing in the 
technique of diagnosis because endoscopy had not been 
used in the older study and it’s possible to diagnose many 
of cardiac tumors as esophageal cancer (due to dysphagia) 
(Islami et al., 2004). 
In another study from Iran (Abdi-Rad et al., 2006) 
researchers showed a trend of increasing of proximal 
tumors and the trend was more obvious in lower ages. 
In our study, the mean age was about 10 years more than 
above study. This could be a possible explanation for our 
results that showed no significant trend toward proximal 
tumors. Pivotal role of endoscopy in diagnosis of tumors is 
a key to interpret age and topography changes in our study. 
Samples in our study were enrolled from archive of 
pathology ward of Bou-Ali Sina (Avicenna) hospital that 
has found out as the first endoscopy and pathology centre 
in the city. 
Throughout the study, ratio of diffuse/intestinal type 
and mean age of gastric cancer has been increased but 
mean age of cases with diffuse type was lower than 
intestinal. 
One possible explanation for this diversity might be 
involving younger and more symptomatic patients for 
endoscopy and when gradually the technique became more 
popular, older and less symptomatic patient underwent 
endoscopy. With above statement, we can explain a 
predominance of cardiac cancer compared to all types of 
gastric cancers because it is more symptomatic (Islami et 
al., 2004; Kumar, 2007).
Although there was no trend of proximal migration 
of the gastric cancer, with focusing on the last two five 
years period of the study, we might find a reduction in the 
percentage of distal areas from 42.5 to 35.3 due to fewer 
defects in topographic determination. 
Limitations, we had a few cases of exclusion due 
to either failure to find blocks or conflict in definitive 
diagnosis of malignancy (8 cases). Morphological 
determination based on WHO classification was difficult 
in some cases (or sometimes impossible) because of 
endoscopic origination of samples. Although that was 
not a serious problem to validity of data because Lauren’s 
classification is more common todays.
In some samples, differentiations between intestinal 
and diffuse types, diffuse type and malignant lymphoma 
were not possible due to inadequate amount of sample 
or necrosis and lack of IHC staining. Altogether, these 
discrepancies were not notable to affect results of the 
study.
In conclusion, morphological changes and types of 
the tumors in the present study were mostly similar to 
others reports. A single morphological classification for all 
samples was one of the strengths of this study in contrast 
with registry-based studies such a classification neither 
unchangingly exists nor does not exist.
Morphological study of esophageal and gastric cancers 
showed similar changes to other studies. Morphological 
trends (increasing esophageal adenocarcinoma and 
diffuse/intestinal ratio in stomach cancer) could be a result 
of changing in nutritional habits or H.pylori treatment. 
Male/female ratio in gastric cancer and AC of esophagus 
in this study was more than other studies (may be due to 
difference in risk factors).
Topography of gastric cancer in our study was 
compatible to the studies from low incidence regions 
(domestic or abroad) like southern areas of the country 
but cardiac involvement was not so high. We couldn’t 
find a topographical trend toward cardia that could be 
a real or fake result. It’s important to consider the roles 
of diagnostic criteria, type of sample for pathological 
diagnosis (endoscopic or surgical) and the popularity 
of using endoscopic procedures in the society as some 
determinants in epidemiological and topographical 
changes of cancers. In addition, it seems that there’s a 
relationship between topographical changes of esophageal 
and gastric cancers with the frequency of disease in a 
geographical area.
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